Respiratory Tract Infection
📧 Sign up to get email alerts when something new happens for Respiratory Tract Infection.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-05EMA Authorised: Arikayce liposomal (amikacin sulfate) — Insmed Netherlands B.V.
EMA authorised Arikayce liposomal (amikacin sulfate) for respiratory tract infections, granted orphan designation.
-
EMA approval · 2026-03-23EMA Authorised: Vaborem (meropenem trihydrate;vaborbactam) — Menarini International Operations Luxembourg S.A.
The European Medicines Agency authorised Vaborem, a meropenem trihydrate and vaborbactam combination, for use in several infections. It cove…
-
FDA approval · 2008-09-22FDA Approved: CEPHALEXIN — Supplemental Application (AMELLA PHARMA, LLC)
FDA approved a supplemental application for Cephalexin from Amella Pharma, LLC.